Delivery Order SPE2DB22D3004-SPE2DB24FRM37
Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,136.80 with a firm fixed price for the delivery of 24,000 units of the medication PERTZYE DR 80S capsule. The contract has an ultimate completion date of July 18, 2025 and was awarded on July 17, 2025. This contract award is not designated as a set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,144.30 firm fixed price delivery order contract is for the supply of 24,000 units of the prescription drug PERTZYE DR 200S. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of PERTZYE DR 100S capsules, with a firm fixed price ceiling value of $24,368.76. The ultimate completion date for this delivery order is May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 units of PERTZYE DR 24,000 UNIT CAPSULE UU 80S, a pharmaceutical product. The contract has a firm fixed price of $7,757.79 and an ultimate completion date of June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $1,378.69 to provide Pylera capsules. This is not a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,169.72 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price structure and is set to expire on August 28, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,214.95 firm-fixed-price delivery order is for the supply of a pharmaceutical product, specifically "4564731242 ! SPS 15 GM/60 ML SUSPENSION UD 60ML." The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $49,853.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has an ultimate completion date of April 18, 2024 and is not set aside. Amerisourcebergen, a major pharmaceutical distributor, will provide a range of prescription medications, over-the-counter drugs, and medical supplies to support the DLA's medical supply chain operations. This delivery order...